Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Glioma. 2018 Jul-Aug;1(4):132-135. doi: 10.4103/glioma.glioma_17_18. Epub 2018 Aug 30.

2.

Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.

Lehrer S, Rheinstein PH.

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.

PMID:
30194079
3.

Alzheimer's Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database.

Lehrer S, Rheinstein PH.

J Alzheimers Dis Rep. 2018;2(1):111-115. doi: 10.3233/ADR-170033. Epub 2018 Jun 29.

4.

Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Clin Neurol Neurosurg. 2018 Sep;172:112-115. doi: 10.1016/j.clineuro.2018.07.003. Epub 2018 Jul 5.

PMID:
29986195
5.

Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the SGK1 Gene Are Associated with Poorer Survival.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):273-278. doi: 10.21873/cgp.20085.

6.

In primary glioblastoma fewer tumor copy number segments of the F13A1 gene are associated with poorer survival.

Lehrer S, Dembitzer FR, Rheinstein PH, Rosenzweig KE.

Thromb Res. 2018 May 4;167:12-14. doi: 10.1016/j.thromres.2018.05.001. [Epub ahead of print] No abstract available.

PMID:
29753279
7.

Mutations of the PDE5A Gene Confer a Survival Advantage in Patients with Colon Cancer.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Prev Res (Phila). 2018 Jul;11(7):439-440. doi: 10.1158/1940-6207.CAPR-18-0105. Epub 2018 May 3. No abstract available.

PMID:
29724712
8.

Periodontal Disease and Incident Cancer-Letter.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):614-615. doi: 10.1158/1055-9965.EPI-17-0726. No abstract available.

PMID:
29716930
9.

Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer. 2018 May 15;124(10):2253. doi: 10.1002/cncr.31262. Epub 2018 Mar 15. No abstract available.

PMID:
29543320
10.

Nasal steroids as a possible treatment for Alzheimer's disease.

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152. Review.

11.

Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States.

Lehrer S, Rheinstein PH, Rosenzweig KE.

J Alzheimers Dis. 2017;59(2):737-741. doi: 10.3233/JAD-170308.

PMID:
28671130
12.
13.
14.

Is Alzheimer's Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?

Lehrer S, Rheinstein PH.

Am J Alzheimers Dis Other Demen. 2015 May;30(3):225-7. doi: 10.1177/1533317514545478. Epub 2014 Aug 5.

PMID:
25100747
15.

Editor's Note.

Yang B, Rheinstein PH.

Discov Med. 2005 Apr;5(26):120. No abstract available.

16.

Overview of the US Food and Drug Administration's reform legislation.

Rheinstein PH.

Clin Ther. 1998;20 Suppl C:C4-11. Review.

PMID:
9915084
17.

Keeping abreast of new drug approvals and labeling changes.

Rheinstein PH, Tsai VW.

Am Fam Physician. 1998 Sep 15;58(4):995-8. No abstract available.

18.

Significant FDA approvals in 1997.

Rheinstein PH, Akbari B.

Am Fam Physician. 1998 Jun;57(11):2865-8. No abstract available.

19.

Prescription to over-the-counter drug switches.

Rheinstein PH.

Am Fam Physician. 1997 Sep 15;56(4):1211-4. No abstract available.

PMID:
9310067
20.

Significant FDA approvals in 1996.

Rheinstein PH.

Am Fam Physician. 1997 Jun;55(8):2855-8. No abstract available.

PMID:
9191461
21.

Children and tobacco: the FDA's final rule.

Rheinstein PH, McGinnis TJ, Nightingale SL.

Am Fam Physician. 1997 Mar;55(4):1441-4. Review. No abstract available.

PMID:
9092294
22.

Seven tips for sun sense.

Rheinstein PH.

Am Fam Physician. 1996 Sep 15;54(4):1385-8. No abstract available.

PMID:
8816578
23.

Ways to access FDA information.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1996 Jul;54(1):353-8. No abstract available.

PMID:
8677842
24.

Significant FDA approvals in 1995.

Rheinstein PH.

Am Fam Physician. 1996 Apr;53(5):1871-4. No abstract available.

PMID:
8623703
25.

The patient information and education initiative.

Rheinstein PH, McGinnis TJ, Nightingale SL.

Am Fam Physician. 1995 Dec;52(8):2377-8, 2381-2. No abstract available.

PMID:
7484726
26.

Children and tobacco: the Clinton administration proposal.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1995 Sep 15;52(4):1205-8. No abstract available.

PMID:
7668208
27.

Home test kits and monitors.

Rheinstein PH, Thomas A.

Am Fam Physician. 1995 Jul;52(1):293-6. Review. No abstract available.

PMID:
7604768
28.

Significant FDA approvals in 1994.

Rheinstein PH.

Am Fam Physician. 1995 Mar;51(4):888-90. No abstract available.

PMID:
7887364
29.

Avoiding problems with liquid medications and dosing devices.

Rheinstein PH.

Am Fam Physician. 1994 Dec;50(8):1771-2. No abstract available.

PMID:
7619108
30.

Access to investigational drugs for treatment purposes.

Nightingale SL, Kimbrough CA, Rheinstein PH.

Am Fam Physician. 1994 Sep 15;50(4):845-7. No abstract available.

PMID:
8079913
31.

The Mammography Quality Standards Act of 1992.

Hoffman FA, Rheinstein PH, Houn F.

Am Fam Physician. 1994 Jun;49(8):1965-70. No abstract available.

PMID:
8203325
32.

The generic drug approval process.

Rheinstein PH.

Am Fam Physician. 1993 Dec;48(8):1357-60. No abstract available.

PMID:
8249762
33.

MedWatch: the FDA medical products reporting program.

Rheinstein PH.

Am Fam Physician. 1993 Sep 15;48(4):636-8. No abstract available.

PMID:
8379493
34.

Shellfish-borne illnesses.

Rheinstein PH, Klontz KC.

Am Fam Physician. 1993 Jun;47(8):1837-40. Review. No abstract available.

PMID:
8498290
35.

Update on food labeling.

Rheinstein PH.

Am Fam Physician. 1993 Mar;47(4):979-82. No abstract available.

PMID:
8438688
36.

Healthy people 2000 initiative.

Rheinstein PH.

Am Fam Physician. 1992 Dec;46(6):1829-32. No abstract available.

PMID:
1456200
37.

Reporting of adverse drug events: a key to postmarketing drug safety.

Rheinstein PH.

Am Fam Physician. 1992 Sep;46(3):873-4. No abstract available.

PMID:
1514478
38.

Drug company sponsorship of education: the response to the FDA draft concept paper.

Lazar EJ, Banks D, Graham C, Adams D, Rheinstein PH, Gross M, Witt AM.

JAMA. 1992 Jul 1;268(1):53-4. No abstract available.

PMID:
1608109
39.

Medication errors.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1992 Jun;45(6):2720-2. No abstract available.

PMID:
1595519
40.

Food labeling reforms for 1992.

Rheinstein PH, Bagley GP.

Am Fam Physician. 1992 Mar;45(3):1349-53. No abstract available.

PMID:
1543114
41.

Update on breast implants.

Rheinstein PH, Bagley GP.

Am Fam Physician. 1992 Feb;45(2):472-3. No abstract available.

PMID:
1739038
42.

Update on breast implants.

Rheinstein PH, Hoffman FA.

Am Fam Physician. 1991 Dec;44(6):2227-9. No abstract available.

PMID:
1746397
43.

The FDA as an information source for family physicians.

Rheinstein PH.

Am Fam Physician. 1991 Sep;44(3):1037-41. No abstract available.

PMID:
1877417
44.

Significant FDA approvals in 1990.

Rheinstein PH.

Am Fam Physician. 1991 Jun;43(6):2257-8. No abstract available.

PMID:
2042556
45.

FDA regulation of prescription drug advertising.

Peck CC, Rheinstein PH.

JAMA. 1990 Nov 14;264(18):2424-5. No abstract available.

PMID:
2232001
46.

Regulatory status of pancreatic enzyme preparations.

Rheinstein PH.

JAMA. 1990 May 9;263(18):2491-2. No abstract available.

PMID:
2329638
47.

Therapeutic inequivalence.

Rheinstein PH.

Drug Saf. 1990;5 Suppl 1:114-9. Review.

PMID:
2182054
48.

Reassurance about generic drugs.

Faich GA, Morrison J, Dutra EV Jr, Hare DB, Rheinstein PH.

N Engl J Med. 1987 Jun 4;316(23):1473-5. No abstract available.

PMID:
3574426
49.

Regulation of O-T-C drug advertising: the FDA "prescription".

Rheinstein PH, Mazis MB.

J Am Pharm Assoc. 1976 Sep;16(9):505-6, 524. No abstract available.

PMID:
965685
50.

Drug labeling as a standard for medical care.

Rheinstein PH.

J Leg Med (N Y). 1976 Jan;4(1):22-4. No abstract available.

PMID:
1082473

Supplemental Content

Loading ...
Support Center